Ketamine hydrochloride injection

DRUG5 trials

Sponsors

Juvenile Bipolar Research Foundation, New York State Psychiatric Institute, Integrative Psychiatry Institute, University of Rochester, Boston Children's Hospital

Conditions

Bipolar DisorderChronic PainDepression, BipolarDepression, UnipolarPsychedelic ExperiencesPsychology, PerceptualSickle Cell CrisisSickle Cell Disease

Early Phase 1

Ketamine Therapy Experiential Education Study

Integrative Psychiatry InstitutePsychedelic Experiences, Psychology, Perceptual, Therapeutic Alliance

Start: 2022-09-30End: 2024-09-30Target: 500Updated: 2022-07-21

Phase 2

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder

TerminatedNCT01504659

Juvenile Bipolar Research FoundationBipolar Disorder

Start: 2012-07-31End: 2016-11-30Updated: 2017-03-16

Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression

Not yet recruitingNCT07247006

University of RochesterChronic Pain, Treatment Resistant Depression (TRD)

Start: 2026-06-01End: 2028-03-01Target: 25Updated: 2026-04-23

Phase 3

Optimal Timing of Ketamine Initiation for SCD Pain

Not yet recruitingNCT07450430

Boston Children's HospitalSickle Cell Crisis, Sickle Cell Disease

Start: 2026-02-01End: 2030-02-01Target: 90Updated: 2026-03-09

Phase 4

IM Ketamine vs Midazolam for Suicidal ER Patients

SuspendedNCT04640636

New York State Psychiatric InstituteDepression, Bipolar, Depression, Unipolar, Suicidal Ideation

Start: 2021-02-09End: 2028-03-01Target: 90Updated: 2026-05-26

Related Papers

Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale

Journal of Affective Disorders Reports2023-12-021 citations